Message Board
The Australian Red Cross Blood Service currently performs infectious disease screening using a combination of serological methods for HIV, HBV, HCV, HTLV and syphilis, and nucleic acid testing (NAT) for HIV and HCV.
In 2010, the Blood Service is replacing the current semi-automated NAT system and duplex assay (Procleix HIV-1/HCV Assay) with a fully automated testing system (Procleix Tigris) and a new triplex assay for the simultaneous detection of HIV-1 RNA, HCV RNA and HBV DNA (Procleix Ultrio Assay).
We are pleased to be able to share the national results of our 2009 Customer Satisfaction Survey with you.
Our annual survey is one of the tools we use to help us focus our efforts on the areas of our service which are most important to you, our customer. State based reports are now available.